The lack of PTEN in tumor cells, which can be biallelic, decreases T-cell-mediated tumor killing, CD8+ T-cell infiltration into tumors, successful T-cell expansion from resected tumors and outcomes with PD-1 inhibitor therapy. This evidence concerns the gene PDCD1 and neoplasm.